#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myotonic dystrophy Barth syndrome Pulmonary sarcoidosis Von Willebrand's disease Chronic lymphocytic leukaemia Adenocarcinoma pancreas Crohn's disease Pulmonary arterial hypertension Acute myeloid leukaemia Nephropathy Short-bowel syndrome Kaposi's sarcoma Familial haemophagocytic lymphohistiocytosis Interstitial lung disease B-cell lymphoma More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Trials in Disease Myelodysplastic syndrome with excess blasts VEXAS syndrome Familial haemophagocytic lymphohistiocytosis – Life with Disease Netherton’s syndrome – Trials in Disease Leukoencephalopathy – Life with Disease Primary biliary cholangitis – Life with Disease Osteosarcoma Cholangitis sclerosing – Basic Information Hepatic angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thiotepa Enalapril Magnesium Chloride Hexahydrate Cetrelimab Benzocaine Mometasone Furoate Ph. Eur. ZUNIBERGENE ROCPARVOVEC Corline Heparin Conjugate Romidepsin Potassium Canrenoate R2R01 Dapirolizumab Pegol Erenumab Cimetidine Hydrochloride Dimeticone ADS-019 Pembrolizumab Iodixanol Dosulepin Hydrochloride Basiliximab More therapies…

    Learn about Your Condition

    Psoriasis Neurogenic bladder Mitral valve disease Alpha-1 antitrypsin deficiency Electronic cigarette user Metastases to peritoneum Univentricular heart Lipid metabolism disorder Shprintzen-Goldberg syndrome Head and neck cancer Haemoptysis Breast proliferative changes Shock Fallopian tube cancer stage IV Body mass index increased More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Psilocybin Therapy for Hospitalized Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Belgium

  • Study on Rimegepant and Capsaicin for Migraine in Lean and Obese Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    • Obesity
    Investigated Drugs:
    • Rimegepant
    • Capsaicin
    The Netherlands

  • Study on the Effects of Donepezil on Cognitive and Motor Functions in Elderly Patients with Neurological Disorders

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Donepezil Hydrochloride
    Germany

  • Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    • Polyneuropathy
    Investigated Drugs:
    • LY3848575
    Germany Poland

  • Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Acetylcysteine Amide
    Denmark Iceland

  • Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • NVG-2089
    Belgium Bulgaria France Italy Poland Spain
Previous Page
1 … 88 89 90 91 92 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!